A case of new‐onset acute generalized pustular psoriasis following Pfizer‐BioNTech COVID ‐19 vaccine
- 6 April 2022
- journal article
- letter
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (6) , e15444
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in ItalyDermatology and Therapy, 2021
- De novo generalized pustular psoriasis following Oxford‐AstraZeneca COVID‐19 vaccineClinical and Experimental Dermatology, 2021
- Psoriasis flare‐up associated with second dose of Pfizer‐BioNTech BNT16B2b2 COVID‐19 mRNA vaccineJournal of the European Academy of Dermatology and Venereology, 2021
- A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case reportHealth Promotion Perspectives, 2021
- Generalized pustular psoriasis following COVID ‐19Dermatologic Therapy, 2020
- Generalized exacerbation of psoriasis vulgaris induced by pneumococcal polysaccharide vaccineThe Journal of Dermatology, 2019
- National Survey of Psoriasis Flares after 2009 Monovalent H1N1/Seasonal VaccinesDermatology, 2014
- Interferon-α and viral triggers promote functional maturation of human monocyte-derived dendritic cellsBritish Journal of Dermatology, 2008
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981